Loading candles…
Thyrocare Technologies operates in the healthcare and diagnostic services industries, providing diagnostic healthcare services with a focus on pathology and radiology. The company manages a network of 37 laboratories across India and has expanded its operations internationally to Tanzania. It offers diagnostic services, including clinical chemistry and preventive care services under its Aarogyam brand. Thyrocare Technologies specializes in delivering quality diagnostic services through its extensive laboratory network, supporting preventive health initiatives via its Aarogyam brand.
This page is a live market overview for THYROCARE TECH LTD (THYROCARE) on the NSE. As a listed security, THYROCARE TECH LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for THYROCARE before placing trades on tick2trade.
As of the latest feed, THYROCARE last traded at ₹603.25 on NSE, up ₹5.2 (0.87%) from the previous close of ₹598.05. Today's session range is ₹593.9 – ₹606.6, against a 52-week band of ₹342.55 – ₹617.45. Traded volume today stands at 2.09L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for THYROCARE in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether THYROCARE is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for THYROCARE TECH LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in THYROCARE. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated THYROCARE option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Unaudited Results - Q1-FY26 | Thyrocare Technologies Limited has informed the Exchange about Board Meeting to be held on July 23, 2026 to inter-alia consider and approve the Unaudited Sta… | 23 Jul 2026 |
| Audited Results - Q4 & FY26 | Thyrocare Technologies Limited has informed the Exchange about Board Meeting to be held on Thursday, May 07, 2026 to consider and approve the Audited Standal… | 7 May 2026 |
| Unaudited Results - Q3-FY26 | Thyrocare Technologies Limited has informed that the Board Meeting is scheduled to be held on January 28, 2026 to consider and approve the Unaudited Standalo… | 28 Jan 2026 |
| Unaudited Results - Q2 & FY25 | To consider and approve the Unaudited financial results for quarter and half year ended September 30, 2025, Declaration of an Interim Dividend and Proposal … | 14 Oct 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 23 Jul 2025 |
| Audited Results - Q4 & FY25 | To consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2025, and to recommend … | 23 Apr 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.